Lexaria Bioscience Corporation (LEXX)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current LEXX market cap is 24.57M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | -4k | 151k | 145k | 84k | 84k |
| Operating Income | -1.07M | -1.14M | -668k | -1.74M | -2.2M |
| Net Income | -1.24M | -1.18M | -650k | -1.78M | -2.19M |
| Year End August 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 384k | 726k | 255k | 226k | 464k |
| Operating Income | -1.4M | -5.71M | -7.38M | -6.53M | -5.75M |
| Net Income | -4.23M | -4.03M | -7.27M | -6.67M | -5.8M |
| Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.08M | 3.63M | 6.35M | 10.02M | 8.87M |
| Total Liabilities | 404k | 254k | 204k | 270k | 1.21M |
| Total Equity | 2.68M | 3.37M | 6.15M | 9.75M | 7.66M |
| Year End August 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.83M | 13.27M | 7.83M | 3.08M | 8.87M |
| Total Liabilities | 346k | 203k | 201k | 404k | 1.21M |
| Total Equity | 2.48M | 13.06M | 7.63M | 2.68M | 7.66M |
| Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.88M | -1.18M | -1.8M | -3.07M | -4.96M |
| Investing | -170k | -40k | -97k | -119k | -189k |
| Financing | 1.59M | 1.82M | 5.27M | 10.32M | 10.32M |
| Year End August 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.66M | -3.99M | -4.88M | -5.88M | -4.96M |
| Investing | -27k | 194k | -180k | -170k | -189k |
| Financing | 2.7M | 13.42M | -45k | 1.59M | 10.32M |
| Market Cap | 24.57M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 17.55M |
| Average Volume (1 week) | 139.53k |
| Average Volume (1 Month) | 133.15k |
| 52 Week Change | -55.27% |
| 52 Week High | 6.85 |
| 52 Week Low | 1.15 |
| Spread (Intraday) | 0.04 (2.86%) |
| Company Name | Lexaria Bioscience Corporation |
| Address |
100-740 mccurdy rd kelowna, british columbia V1X 2P7 |
| Website | https://www.lexariabioscience.com |
| Industry | crude petroleum & natural gs (1311) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
